03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Zolapine 20mg* : | |
Type | Medicine Non Marketed |
Originator | G |
Agent | Pharmaline |
Distributor | Pharmaline |
Laboratory | Pharmaline Laboratories |
Responsible Party | Pharmaline SAL |
Origin | Lebanon |
Manufacturer | Pharmaline SAL* |
Manufacturing Type | G |
Origin | Lebanon |
ATC | N05AH03 |
Zolapine 20mg* :
Zolapine 20mg* :
Zolapine 20mg* :
Zolapine 20mg* :
Zolapine 20mg* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Zolapine 20mg* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal distension | Uncommon |
Akathisia | Common |
Alopecia | Uncommon |
ALT increased | Very Common |
Amenorrhoea (amenorrhea) | Uncommon |
Amnesia | Uncommon |
Anticholinergic syndrome | Common |
Arthralgia (Pain joint) (Joint ache) | Common |
AST increased | Very Common |
Asthenia | Common |
Bilirubin total increased | Uncommon |
Blood alkaline phosphatase increased | Common |
Blood bilirubin decreased | Very Common |
Blood cholesterol increased | Common |
Blood creatine phosphokinase increased | Common |
Blood glucose increased | Common |
Blood prolactin increased | Very Common |
Blood triglycerides increased | Common |
Body temperature increased | Common |
Bradycardia | Uncommon |
Breast enlargement | Uncommon |
Cerebrovascular accident | Not known |
Cholestatic liver injury | Rare |
Coma | Uncommon |
Constipation | Common |
Death | Not known |
Deep vein thrombosis | Uncommon |
Diabetes mellitus | Uncommon |
Dizziness | Common |
Dry mouth (Xerostomia) | Common |
Dysarthria | Uncommon |
Dyskinesia | Common |
Dystonia | Uncommon |
ECG QT prolonged | Uncommon |
Eosinophilia | Common |
Epistaxis (Nasal bleeding) | Uncommon |
Erectile dysfunction | Common |
Erythema | Common |
Fall | Very Common |
Fatigue | Common |
Gait abnormal | Very Common |
Galactorrhoea | Uncommon |
Gamma-GT increased | Very Common |
Glucosuria (Glycosuria) | Common |
Gynecomastia (Gynaecomastia) | Uncommon |
Hallucination | Very Common |
Hallucination, visual | Common |
Hepatitis | Rare |
Hepatocellular injury | Rare |
Hypersensitivity | Uncommon |
Hypersomnia | Very Common |
Hypothermia | Rare |
Increased appetite | Common |
Ketoacidosis | Uncommon |
Lethargy | Very Common |
Leucopenia (Leukopenia) | Common |
Libido decreased | Common |
Mixed liver injury | Rare |
Neuroleptic malignant syndrome | Rare |
Neutropenia | Common |
Oculogyration | Uncommon |
Oedema | Common |
Orthostatic hypotension | Very Common |
Pancreatitis | Rare |
Parkinsonism | Common |
Parkinsonism aggravated | Very Common |
Photosensitivity reaction | Uncommon |
Pneumonia | Common |
Priapism | Rare |
Pulmonary embolism | Uncommon |
Pyrexia | Common |
Rhabdomyolysis | Rare |
Sedation | Very Common |
Seizures | Uncommon |
Skin rash | Common |
Somnolence | Very Common |
Speech disorder | Common |
Sudden death | Rare |
Tardive dyskinesia | Uncommon |
Thrombocytopenia (Thrombopenia) | Rare |
Thromboembolism | Uncommon |
Tremor aggravated | Not known |
Uric acid high | Common |
Urinary hesitation | Uncommon |
Urinary incontinence | Common |
Urinary retention | Uncommon |
Ventricular fibrillation | Rare |
Ventricular tachycardia | Rare |
Weight increased (weight gain) | Very Common |
Withdrawal syndrome | Rare |
Withdrawal syndrome neonatal | Not known |
Zolapine 20mg* :
NB : Products With Same Indication |
Different Units By MoH Code
Zolapine 20mg* MoH 9417 :
Form | Tablet, Orodispersible |
Package Size | Box of 30 |
Strength | 20mg |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 24918/1 |
Submission date | 01/01/2018 |
Registration Year | 2018 |
Archived Date | 01/02/2022 |
You have to register to view this info
Drop File